Tom has a broad range of experience advising on public and private M&A, private equity and joint ventures.
Tom acts for a variety of clients across different sectors and jurisdictions.
Advising Jazz Pharmaceuticals plc on its acquisition of GW Pharmaceuticals plc for a total consideration of $7.2bn.
Advising Smith & Williamson on its merger with the Tilney Group, creating the UK’s leading integrated wealth management group.
Advising Spectris in relation to its acquisition of Concept Life Sciences from Equistone Partners.
Advising Epiris on its acquisition of the IFG Group.
Advising L3 Harris on its acquisition of C.K. Industrial Engineers Limited.
Advising Keyhaven Capital Partners on the sale of Augur Financial Opportunities II to SALU Capital.
Advising Venn Capital Partners on its sale of a majority stake to ARA Asset Management.
